Prosecution Insights
Last updated: August 17, 2026

Examiner: FAROOQ, MAHMOOD

Tech Center 3700 • Art Units: 3783

This examiner grants 67% of resolved cases

Performance Statistics

66.7%
Allow Rate
-3.3% vs TC avg
19
Total Applications
+0.0%
Interview Lift
868
Avg Prosecution Days
Based on 3 resolved cases, 2023–2026

Rejection Statute Breakdown

4.4%
§101 Eligibility
20.7%
§102 Novelty
44.6%
§103 Obviousness
30.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18706853 Methods for Administration of Drug to the Retina Non-Final OA Georgia Tech Research Corporation
18705172 Drug Delivery Investigation Device Non-Final OA Becton, Dickinson and Company
18238595 Non-Integrated Vascular Access System with Stabilization Non-Final OA Becton, Dickinson and Company
18113966 SHAPE-CHANGEABLE SYRINGE PACKAGE SYSTEM Non-Final OA Becton, Dickinson and Company
18707218 ADMINISTRATION DEVICE Non-Final OA TERUMO KABUSHIKI KAISHA
18256441 METHODS AND DEVICES FOR PROVIDING OXYGEN TO ENCAPSULATED CELLS Non-Final OA CORNELL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month